Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03583710 |
| Consolidated Lead Sponsor | MD Anderson Cancer Center |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 240 participants (ESTIMATED) |
| Registered Start Date | 2018-08-20 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| University of Michigan Rogel Cancer Center | Ann Arbor, MI | Open Hospital Dossier -> |
| Washington University and Siteman Cancer Center | Saint Louis, MO | Open Hospital Dossier -> |
| MD Anderson Cancer Center | Houston, TX | Open Hospital Dossier -> |
| Centre Georges-François Leclerc | Dijon, France | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for MD Anderson Cancer Center across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.